Skip to main content
. Author manuscript; available in PMC: 2015 Jul 30.
Published in final edited form as: Ann Surg Oncol. 2012 Aug 3;19(12):3888–3895. doi: 10.1245/s10434-012-2554-5

TABLE 2.

Characteristics of sentinel lymph node biopsy patients

SLNB performed (N = 62) Positive SLNB (N = 18) Negative SLNB (N= 44) p value
Age group
    <12 years 2 1 1
    12–17 years 32 9 23
    18–20 years 28 8 20
Gender, n (%) NS
    Male 28 (45.2) 9 (50) 19 (43.2)
    Female 34 (54.8) 9 (50) 25 (56.8)
Histologic type, n (%) NS
    Superficial spreading 29 (46.8) 6 (33.3) 23 (52.3)
    Nodular 14 (22.6) 5 (27.8) 9 (20.5)
    Spitzoid 3 (4.8) 1 (5.6) 2 (4.5)
    Other 4 (6.5) 1 (5.6) 3 (6.8)
    Not specified 12 (19.4) 5 (27.8) 7 (15.9)
Location, n (%) NS
    Head and neck 24 (38.7) 5 (27.8) 19 (43.2)
    Trunk 18 (29) 6 (33.3) 12 (27.3)
    Extremities 20 (32.2) 7 (38.9) 13 (29.5)
Breslow thickness (mm)
    Median 1.60 2.55 1.30 <0.05*
    Range 0.42–10.4 1.05–6.2 0.42–10.4
Mitotic rate, n (%)a NS
    ≥1/mm2 25 (67.6) 12 (85.7) 13 (56.5)
    <1/mm2 12 (32.4) 2 (14.3) 10 (43.5)
Ulceration, n (%)a 17 (35.4) 8 (57.1) 9 (26.5) NS
Regression, n (%)a 2 (5.0) 1 (9.1) 1 (3.4) NS
VGP, n (%)a 37 (94.9) 11 (100) 26 (92.9) NS
LVI, n (%)a 1 (2.6) 1 (8.3) 0 NS

SLNB sentinel lymph node biopsy, VGP vertical growth phase, LVI lymphovascular invasion, NS not significant

*

Significant on univariate analysis for Breslow thickness versus SLNB status

a

Data unavailable or missing for mitotic rate in 25 cases, for ulceration in 14 cases, for regression in 22 cases, for VGP in 23 cases, and for LVI in 23 cases